close-to-significantp = 0.0648
These relapses had an effect on mice survival ( Figure 5 C): the cetuximab/rapamycin combination was found to result in longer survival compared to the cetuximab/rapamycin/irradiation (close-to-significant difference: p = 0.0648) and to the cetuximab/irradiation (significant difference: p = 0.0015) regimens. 3.